Abstract. The role of extracellular calcium in the interaction between intracellular cAMP and nitric oxide (NO)/ cGMP on the contractility of rat diaphragm pretreated with cumulative concentrations of aminophylline (0.36 -3.60 mM) was investigated. In a Ca
G
-nitro-L-arginine methyl ester L-NAME (N G -nitro-L-arginine methyl ester) is a nonselective inhibitor of nitric oxide synthase (NOS), and cardiovascular effects of this potent inhibitor of NOS have been extensively analyzed (1) . However, after discovery of the nitric oxide (NO) in the skeletal muscle, the influence of NO and inhibitors of NOS on muscle contractillity was also investigated (2 -4) . It is known that the neuronal isoform of NOS (nNOS) is predominantly localized postsynaptically at the neuromuscular junction in the skeletal muscle (5) and that the enzyme responsible for NO production is activated during repetitive contraction of the skeletal muscle. Therefore, during passive incubation, a mouse diaphragm produces approx. 13 pmol / mg per min of NO, while during active contraction, diphragm NOS activity increases eightfold (6) . It is documented that the activity of nNOS is regulated by calcium ions (7) . NO produced by nNOS modulates excitation-contraction coupling both directly (S-nitrosylation of sarcoplasmic calcium ryanodine receptor and / or Ca 2+ -ATPase) and indirectly (via cGMP and/ or interaction with reactive oxygen species) (3) .
It was already shown that cumulative concentrations of aminophylline (AMPh) (0.36 -3.60 mM) produce an increase of the isometric contraction of the isolated rat diaphragm during direct electrical stimulation (8) . AMPh-induced potentiation requires the presence of extracellular Ca 2+ ions (9) . Calcium release from the sarcoplasmic reticulum and increased influx of extracellular calcium through sarcolemal L-voltage Ca 2+ channels, as well as cAMP, are probably also involved in the stimulatory action of AMPh (8 -10) .
In one of our previous studies, the interaction between L-NAME and AMPh on the contractility of the isolated rat diaphragm was investigated. It was shown that the stimulatory effects of AMPh on muscle contractility were potentiated by L-NAME. The possible mechanisms include interaction between intracellular cAMP, NO/ cGMP, and calcium (11) . The aim of our present study was to further evaluate the role of calcium, one of the postulated mechanisms of this interaction. Such interaction between drugs that have been known to modulate the diaphragm contractility via NO and cAMP/ calcium system may be of a great clinical importance for the treatment of certain respiratory as well as neurological diseases.
The experiments were performed on the isolated rat hemidiaphragm. Wistar rats of both sexes (200 -250 g) were bred and kept under ordinary laboratory conditions. The investigation conforms to the Guide for the care and use of the laboratory animals published by the US National Institutes of Health (NIH publication No. 85-23, revised 1985) .
The isolated hemidiaphragm from male and female rats was suspended in an isolated organ bath of 20-ml capacity. The muscle was immersed in Tyrode solution with a double amount of glucose (11.1 mM) (12) and bubbled with a mixture of 97% O 2 and 3% CO 2 . The composition of Tyrode solution was as follows: 136 mM NaCl, 2.81 mM KCl, 0.105 mM MgCl 2 , 1.08 mM CaCl 2 , 0.417 mM NaH 2 PO 4 , 11.9 mM NaHCO 3 , and 11.1 mM dextrose. The temperature of this solution was 36°C. A separate series of experiments was performed in a Ca
2+
-free medium, which was made by adding 0.025 mM disodium edetate (di-Na-EDTA) to a Ca
-free solution (9) . Two paladore wires (palladium 30% and silver 70%) were used for delivering the pulses for direct electrical stimulation. The diaphragm was secured to one of these wires at several points along the rib line. The other electrode was placed around the upper part of the diaphragm, but was not in contact with the muscle. The initial tension after the 30-min equilibration period was about 5 g.
The preparation was stimulated directly by subtetanic electrical stimulation. The frequency of stimulation was 14 Hz for 2 s, a train of pulses being applied every 12 s (5 times / min). The isometric contractions were recorded with a microdisplacement myograph transducer (F 50; Narco-Bio-System, Inc., Houston, TX, USA) and displayed on paper (Physiograph IV polygraph). Both tension developed (Td) and the maximum rate of rise of tension (dT / dt max) were obtained simultaneously (for details, see ref. 8) .
The experimental designs 1 -3 are shown in Fig. 1 . The effects of the drugs used were expressed as percentage changes of Td (D Td, %) from the corresponding control (C, C-30, L-NAME-30, all with or without Ca
). The following drugs were used: aminophylline (Aminophyllinum ® , Lek, Ljubljana, Slovenia); L-NAME (Sigma, St. Louis, MO, USA); di-sodium-EDTA (Merck KGaA, Darmstadt, Germany); nicardipine and verapamil (Galenika, Belgrade, Serbia). Results are expressed as the mean ± S.E.M. of n determinations. The difference between means was assessed for significance by Student's t-test or one-way analysis of variance (ANOVA followed by post hoc 2-sided Bonferroni's test), when appropriate. Values of P<0.05 were taken as statistically significant (SPSS 8.0 for Windows).
In a normal medium (Tyrode solution with Ca The next step was to investigate the effects of L-NAME on Td in a normal Tyrode solution (L-NAME-30) and in a Ca
-free medium (L-NAME-30 (-Ca 2+ ) ) on muscle pretreated with cumulative concentrations of AMPh (Exp. design 2 and 2a, respectively; Fig. 2C ). It was found that L-NAME (3 mM) (L-NAME 3 ) produced a potentiation of Td after 30 min of incubation of the muscle without stimulation (Exp. design 2, Fig. 2C ). Also, L-NAME 3 significantly potentiated the effect of the second series of addition of the cumulative concentrations of AMPh on Td (Exp. design 2, Fig. 2D ). Consequently, the corresponding controls (C-30 and L-NAME 3 -30, Fig. 2C ) for the second series of addition of AMPh ( Fig. 2: A and D, respectively) were quite different: D Td 9.66 ± 5.0% vs 49.33 ± 11.96%. We have already reported that L-NAME 3 produced very strong potentiation of Td (11) . Because of that, AMPh given in the second series in the presence of L-NAME 3 could cause substantial increase of the diaphragm contractility even with a low concentration. Therefore, Td values after the second addition of the lowest concentration of AMPh (0.36 mM) were 179.01 ± 15.36% vs 140.17 ± 7.05% (AMPh with and without L-NAME 3 -30, respectively; P<0.05), while the same D Td (%) values shown in the figure were 29.67 ± 5.00 and 30.5 ± 3.45, respectively ( Fig. 2: D and A) .
It should be pointed out that the effect of L-NAME in a Ca
-free solution (L-NAME-30 (-Ca 2+ ) ) after 30 min of incubation of the muscle without stimulation (Exp. design 2a) was qualitatively different from its effect in the medium with Ca 2+ (L-NAME-30). Contrary to the potentiating effect of L-NAME on Td, in a Ca 2+ -free medium, Td was almost completely missing (Fig. 2C) . In a Ca
-free medium, L-NAME (1 and 3 mM) in a concentration-dependent manner depressed Td (the effect of 3 mM of L-NAME only is shown in Fig. 2C ). The effect of the later concentration of L-NAME (L-NAME 3 -30 (-Ca 2+ ) ) is significantly different from (C-30 (-Ca 2+ ) ) (Exp. designs 2a and 1a, respectively; Fig. 2C ). Also, the present experiments have shown that the potentiating action of AMPh in the presence of L-NAME 3 on the isometric contraction of the isolated rat diaphragm was almost completely abolished in a Ca 2+ -free medium (Exp. design 2a, Fig. 2E ). At the same time, the effects of the second series of addition of AMPh on Td in the presence of L-NAME (1 mM) were still present, but significantly depressed (not shown in the figure) .
Effects of verapamil and nicardipine on the effect of L-NAME and interaction between AMPh and L-NAME were investigated in a separate series of experiments.
The L-NAME-induced potentiation of Td was antagonized in the presence of nicardipine (20 m M) or verapamil (2.5 m M). The effect of verapamil was significantly more pronounced (Exp. design 3, Fig. 3A) .
However, even in the presence of nicardipine or verapamil, L-NAME still produced statisticaly significant potentiation of the cumulative concentrations of AMPh given in the second series (Exp. design 3, Fig. 3 : B and C, respectively).
It has already been shown that L-NAME (1 -10 mM) potentiates the stimulatory effect of AMPh on the -free medium without drugs, as well as without electrical stimulation; L-NAME-30: the value of Td of the electrically stimulated muscle recorded after 30 min of incubation with L-NAME (1 or 3 mM), as well as without electrical stimulation; L-NAME-30(-Ca 2+ ): the value of Td of the electrically stimulated muscle recorded after 30 min of incubation with L-NAME (1 or 3 mM) in a Ca
-free medium; Ver + L-NAME-30: the value of Td of the electrically stimulated muscle recorded after 30 min of incubation together with L-NAME (3 mM) and verapamil (2.5 mM), as well as without electrical stimulation; Nic + L-NAME-30: the value of Td of the electrically stimulated muscle recorded after 30 min of incubation together with L-NAME (3 mM) and nicardipine (20 mM), as well as without electrical stimulation; AMPh (0.36 -3.60 mM): cumulative concentrations of aminophylline.
contractility of the isolated rat hemidiaphragm in the Ca

2+
-containing medium (11) . Such an effect was obtained only on the muscle pretreated with cumulative concentrations of AMPh (0.36 -3.60 mM). Other authors have shown that L-NAME or L-NNA (N-nitro-Larginine), a deesterified form of L-NAME, in the same concentration range used in our experiments (³1 mM) blocked NOS activity in the skeletal muscle (e.g., rat diaphragm, extensor digitorum longus-EDL) (2, 13). In particular, Alloatti et al. (14) have confirmed that L-NAME (1 mM), but not D-NAME (1 mM), inhibited NOS and antagonized the TNF-a -induced depression of the guinea pig EDL contractility. Also, Abraham et al. (15) reported that L-NNA (10 mM) blocked the cGMP-mediated inhibitory action of NO on the rat diaphragm contractility. However, the precise mecha- nism of such interaction remains to be elucidated. A possible explanation could involve the modulation of calcium metabolism in the isolated diaphragm.
Calcium metabolism in skeletal muscle could be modulated at several levels: e.g. L-voltage Ca 2+ channels of sarcolema, Ca 2+ release channels (ryanodine receptors), and Ca
-ATPase of the sarcoplasmic reticulum. AMPh increases the influx of extracelullar calcium through sarcolemal L-voltage Ca 2+ channels and enhances calcium release from the sarcoplasmic reticulum. Also, NO inhibits calcium current through L-voltage Ca 2+ channels (via cGMP and cGMP-dependent protein kinase) and exerts direct biphasic effects on ryanodine receptors, which depend on NO concentration (inhibition in lower and potentiation in higher concentrations) (4) .
The effect of a second series of addition of AMPh (0.36 -3.60 mM) on Td was potentiated in the absence of any drug (Fig. 2A) . In a Ca 2+ -free medium, stimulatory effects of AMPh on Td were present, but significantly depressed (Fig. 2B) . The removal of extracelullar calcium completely changed the effects of L-NAME (3 mM) itself on Td (Fig. 2C : L-NAME 3 -30 (-Ca 2+ ) vs L-NAME 3 -30). In other words, L-NAME almost completely abolished Td (Fig. 2C) . Also, in a Ca
-free medium, L-NAME decreased or completely abolished the effects of AMPh on Td (1 and 3 mM, respectively; the effect of 3 mM of L-NAME only shown in Fig. 2E ). It is known that nNOS is a Ca 2+ -dependent isoform. Accordingly, its activity is diminished in a Ca 2+ -free medium. However, in the present experiments, L-NAME produced further depression of both Td and the effects of AMPh on Td. Therefore, we presumed that L-NAME exerts some NO-unrelated effect(s) on muscle contractility. The antagonizing effects of L-NAME on muscarinic and nicotinic cholinergic receptors (16) are probably not involved because of the type of the electrical stimulation used.
The incubation of the muscle with calcium antagonists of two chemically different classes (2.5 m M verapamil or 20 mM nicardipine) completely antagonized the stimulatory effect of L-NAME on Td (Fig. 3A) and dT / dt max (not shown in the figure) of the diaphragm pretreating with cumulative concentrations of AMPh. It can be concluded that L-NAME-induced potentiation of Td and dT / dt max depends on Ca 2+ ions. It is well known that micromolar concentrations of calcium antagonists are needed to produce a 50% block in skeletal muscle L-calcium channels (8) . However, calcium antagonist did not modulate the interaction between L-NAME and AMPh. In the presence of nicardipine or verapamil, L-NAME still potentiates the effects of the second series of addition of AMPh (Fig. 3 : B and C, respectively). There are several possible explanations of such an interaction. First, the 50% block of L-voltage Ca 2+ channels of sarcolema induced by nicardipine or verapamil is sufficient for the strong inhibition of the L-NAME-induced potentiation of Td. However, such a block of Ca 2+ current could be at the same time insufficient to prevent L-NAME-induced potentiation of the second series of addition of AMPh. Second, the present data support our previous hypothesis (8) that the interaction between L-NAME and AMPh is more complex. As NO production was blocked by L-NAME, the amount of NO was not enough to activate soluble GC. Decreased cGMP-induced stimulation of phosphodiesterase (PDE)2 (a skeletal muscle isoform of PDE) leads to decreased degradation of cAMP (17) . Increased cAMP facilitates the release and uptake of calcium in sarcoplasmic reticulum.
In conclusion, L-NAME in millimolar concentrations depressed the muscle contractility in a Ca
-free medium during direct subtetanic electrical stimulation, and such an effect could not be explained by the specific inhibition of nNOS only or cholinergic receptor antagonism. In addition, L-NAME completely abolished the effect of AMPh on diaphragm contractility in a Ca 2+ -free medium. In contrast, L-voltage Ca 2+ channel blockers (verapamil and nicardipine) did not significantly change the L-NAME-induced potentiation of the stimulatory effect of AMPh in a medium with Ca
. It seems that the influx of extracellular calcium through L-voltage Ca 2+ channels of sarcolema is not necessary for such an interaction between L-NAME and AMPh. Finally, our results clearly show that calcium antagonists (i.e., verapamil and nicardipine) extensively used in clinical practice do not influence the interaction between substances which modulate NO system activity and cAMP levels in the skeletal muscle.
